chloroquine has been researched along with coprogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sweeney, GD | 1 |
| Asami, Y; Hanaki, H; Hokari, R; Inahashi, Y; Ishii, T; Ishiyama, A; Iwatsuki, M; Koike, R; Matsui, H; Muramatsu, R; Noguchi, C; Nonaka, K; Ōmura, S; Ouchi, T; Teruya, T; Tozawa, M; Watanabe, Y | 1 |
1 review(s) available for chloroquine and coprogen
| Article | Year |
|---|---|
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
Topics: Animals; Bloodletting; Carboxy-Lyases; Chloroquine; Chromatography, High Pressure Liquid; Disease Models, Animal; Feces; Female; Heme; Hexachlorobenzene; Humans; Hydroxamic Acids; Iron; Lead Poisoning; Male; Mice; Polychlorinated Dibenzodioxins; Porphyrias; Porphyrins; Rats; Skin Diseases; Uroporphyrinogen Decarboxylase | 1986 |
1 other study(ies) available for chloroquine and coprogen
| Article | Year |
|---|---|
Clonocoprogens A, B and C, new antimalarial coprogens from the Okinawan fungus Clonostachys compactiuscula FKR-0021.
Topics: Antimalarials; Chloroquine; Drug Resistance; Hydroxamic Acids; Hypocreales; Inhibitory Concentration 50; Japan; Plasmodium falciparum | 2020 |